Related Experiment Video
Updated: May 15, 2026
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
The Norwegian Multiple Sclerosis Registry and Biobank
K-M Myhr1, N Grytten, J H Aarseth
1Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway. kjmy@haukeland.no
Unlabelled:
OBJEVTIVES: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with unknown cause and without any curable treatment. Research aiming at defining the pathogenesis of the disease is therefore needed.
Methods:
The Norwegian Multiple Sclerosis Registry and Biobank has been established for systematic collection of clinical and epidemiological data as well as biological samples. Data collection is based on informed consent from the individual patients and recordings by the treating neurologists.
Results:
All researchers have, by application, access to data and biological samples from the Norwegian Multiple Sclerosis Registry and Biobank.
Conclusion:
By this combined effort from both patients and health care personnel, the Registry and Biobank aims to facilitate research for improved understanding of disease mechanisms and improved health care in multiple sclerosis.
